{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:03:35Z","timestamp":1788314615872,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS116058"],"award-info":[{"award-number":["R01 NS116058"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG057290"],"award-info":[{"award-number":["R01 AG057290"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG053999"],"award-info":[{"award-number":["R01 AG053999"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL 149127"],"award-info":[{"award-number":["R01 HL 149127"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG028383"],"award-info":[{"award-number":["P30 AG028383"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"University of Kentucky Research Alliance to Reduce Diabetes-Associated Microvascular Dysfuncto"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Impairment of vascular pathways of cerebral \u03b2-amyloid (A\u03b2) elimination contributes to Alzheimer disease (AD). Vascular damage is commonly associated with diabetes. Here we show in human tissues and AD-model rats that bloodborne islet amyloid polypeptide (amylin) secreted from the pancreas perturbs cerebral A\u03b2 clearance. Blood amylin concentrations are higher in AD than in cognitively unaffected persons. Amyloid-forming amylin accumulates in circulating monocytes and co-deposits with A\u03b2 within the brain microvasculature, possibly involving inflammation. In rats, pancreatic expression of amyloid-forming human amylin indeed induces cerebrovascular inflammation and amylin-A\u03b2 co-deposits. LRP1-mediated A\u03b2 transport across the blood-brain barrier and A\u03b2 clearance through interstitial fluid drainage along vascular walls are impaired, as indicated by A\u03b2 deposition in perivascular spaces. At the molecular level, cerebrovascular amylin deposits alter immune and hypoxia-related brain gene expression. These converging data from humans and laboratory animals suggest that altering bloodborne amylin could potentially reduce cerebrovascular amylin deposits and A\u03b2 pathology.<\/jats:p>","DOI":"10.1038\/s42003-022-04398-2","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T06:04:45Z","timestamp":1672725885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A\u03b2 efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas"],"prefix":"10.1038","volume":"6","author":[{"given":"Nirmal","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal Viswanathan","family":"Velmurugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edric","family":"Winford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kotiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Leibold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Radulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanda","family":"Despa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuey C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8139-6400","authenticated-orcid":false,"given":"Linda J.","family":"Van Eldik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Wilcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Jicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-128X","authenticated-orcid":false,"given":"Larry B.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Powel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-955X","authenticated-orcid":false,"given":"Jeffrey H.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6864-6594","authenticated-orcid":false,"given":"Manuel F.","family":"Navedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8872-158X","authenticated-orcid":false,"given":"Matthew A.","family":"Nystoriak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0929-9315","authenticated-orcid":false,"given":"Andrew J.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6862-2496","authenticated-orcid":false,"given":"Geert Jan","family":"Biessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1790-7376","authenticated-orcid":false,"given":"Claire","family":"Troakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-6449","authenticated-orcid":false,"given":"Florin","family":"Despa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"4398_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 Years. EMBO Mol. Med. 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med."},{"key":"4398_CR2","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/brain\/awn261","volume":"131","author":"D Boche","year":"2008","unstructured":"Boche, D. et al. Consequence of A\u0392 immunization on the vasculature of human Alzheimer\u2019s disease brain. Brain 131, 3299\u20133310 (2008).","journal-title":"Brain"},{"key":"4398_CR3","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/brain\/awz142","volume":"142","author":"JA Nicoll","year":"2019","unstructured":"Nicoll, J. A. et al. Persistent neuropathological effects 14 years following amyloid-\u03b2 immunization in Alzheimer\u2019s disease. Brain 142, 2113\u20132126 (2019).","journal-title":"Brain"},{"key":"4398_CR4","first-page":"e12053","volume":"12","author":"RO Carare","year":"2020","unstructured":"Carare, R. O. et al. Clearance of interstitial fluid (ISF) and CSF (CLIC) group\u2014part of Vascular Professional Interest Area (PIA). Alzheimers Dement. 12, e12053 (2020).","journal-title":"Alzheimers Dement."},{"key":"4398_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"SE Kahn","year":"1990","unstructured":"Kahn, S. E. et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39, 634\u2013638 (1990).","journal-title":"Diabetes"},{"key":"4398_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","volume":"19","author":"WA Banks","year":"1998","unstructured":"Banks, W. A. & Kastin, A. J. Differential permeability of the blood\u2013brain barrier to two pancreatic peptides: insulin and Amylin. Peptides 19, 883\u2013889 (1998).","journal-title":"Peptides"},{"key":"4398_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1124\/pr.115.010629","volume":"67","author":"DL Hay","year":"2015","unstructured":"Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G. & Roth, J. D. Amylin: pharmacology, physiology, and clinical potential. Pharmacol. Rev. 67, 564\u2013600 (2015).","journal-title":"Pharmacol. Rev."},{"key":"4398_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark, P., Andersson, A. & Westermark, G. T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 91, 795\u2013826 (2011).","journal-title":"Physiol. Rev."},{"key":"4398_CR9","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","volume":"178","author":"CA Jurgens","year":"2011","unstructured":"Jurgens, C. A. et al. \u0392-cell loss and \u03b2-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am. J. Pathol. 178, 2632\u20132640 (2011).","journal-title":"Am. J. Pathol."},{"key":"4398_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJM200008103430607","volume":"343","author":"JWM H\u00f6ppener","year":"2000","unstructured":"H\u00f6ppener, J. W. M., Ahr\u00e9n, B. & Lips, C. J. M. Islet amyloid and type 2 diabetes mellitus. N. Engl. J. Med. 343, 411\u2013419 (2000).","journal-title":"N. Engl. J. Med."},{"key":"4398_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced il-1\u03b2 in type 2 diabetes. Nat. Immunol. 11, 897\u2013904 (2010).","journal-title":"Nat. Immunol."},{"key":"4398_CR12","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.2337\/db13-0863","volume":"63","author":"CY Westwell-Roper","year":"2014","unstructured":"Westwell-Roper, C. Y., Ehses, J. A. & Verchere, C. B. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1\u03b2 production and \u03b2-cell dysfunction. Diabetes 63, 1698\u20131711 (2014).","journal-title":"Diabetes"},{"key":"4398_CR13","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1007\/s00125-014-3304-y","volume":"57","author":"DT Meier","year":"2014","unstructured":"Meier, D. T. et al. Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice. Diabetologia 57, 1884\u20131888 (2014).","journal-title":"Diabetologia"},{"key":"4398_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels, G. J. & Despa, F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat. Rev. Endocrinol. 14, 591\u2013604 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"4398_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"K Jackson","year":"2013","unstructured":"Jackson, K. et al. Amylin deposition in the brain: a second amyloid in Alzheimer disease? Ann. Neurol. 74, 517\u2013526 (2013).","journal-title":"Ann. Neurol."},{"key":"4398_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","volume":"185","author":"ME Oskarsson","year":"2015","unstructured":"Oskarsson, M. E. et al. In vivo seeding and cross-seeding of localized amyloidosis. Am. J. Pathol. 185, 834\u2013846 (2015).","journal-title":"Am. J. Pathol."},{"key":"4398_CR17","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1177\/0271678X16657093","volume":"37","author":"N Schultz","year":"2016","unstructured":"Schultz, N., Byman, E., Fex, M. & Wennstr\u00f6m, M. Amylin alters human brain pericyte viability and NG2 expression. J. Cereb. Blood. Flow. Metab. 37, 1470\u20131482 (2016).","journal-title":"J. Cereb. Blood. Flow. Metab."},{"key":"4398_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ana.24992","volume":"82","author":"H Ly","year":"2017","unstructured":"Ly, H. et al. Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia. Ann. Neurol. 82, 208\u2013222 (2017).","journal-title":"Ann. Neurol."},{"key":"4398_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2018.05.003","volume":"69","author":"N Schultz","year":"2018","unstructured":"Schultz, N., Byman, E., Netherlands Brain Bank & Wennstr\u00f6m, M. Levels of retinal IAPP are altered in Alzheimer\u2019s disease patients and correlate with vascular changes and hippocampal IAPP levels. Neurobiol. Aging 69, 94\u2013101 (2018).","journal-title":"Neurobiol. Aging"},{"key":"4398_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.25570","volume":"86","author":"I Martinez\u2010Valbuena","year":"2019","unstructured":"Martinez\u2010Valbuena, I. et al. Amylin as a potential link between type 2 diabetes and Alzheimer disease. Ann. Neurol. 86, 539\u2013551 (2019).","journal-title":"Ann. Neurol."},{"key":"4398_CR21","doi-asserted-by":"crossref","first-page":"e12130","DOI":"10.1002\/trc2.12130","volume":"7","author":"H Ly","year":"2021","unstructured":"Ly, H. et al. The association of circulating amylin with \u03b2-amyloid in familial Alzheimer\u2019s disease. Alzheimers Dement. 7, e12130 (2021).","journal-title":"Alzheimers Dement."},{"key":"4398_CR22","doi-asserted-by":"publisher","first-page":"e199826","DOI":"10.1001\/jamanetworkopen.2019.9826","volume":"2","author":"H Zhu","year":"2019","unstructured":"Zhu, H. et al. Association of plasma amylin concentration with Alzheimer disease and brain structure in older adults. JAMA Netw. Open. 2, e199826 (2019).","journal-title":"JAMA Netw. Open."},{"key":"4398_CR23","doi-asserted-by":"publisher","first-page":"fcz036","DOI":"10.1093\/braincomms\/fcz036","volume":"2","author":"DR Royall","year":"2019","unstructured":"Royall, D. R. & Palmer, R. F., Alzheimer\u2019s Disease Neuroimaging Initiative. Blood-based protein mediators of senility with replications across Biofluids and cohorts. Brain Commun. 2, fcz036 (2019).","journal-title":"Brain Commun."},{"key":"4398_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/mp.2016.35","volume":"22","author":"T Roostaei","year":"2017","unstructured":"Roostaei, T. et al. Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer\u2019s disease. Mol. Psychiatry 22, 287\u2013295 (2017).","journal-title":"Mol. Psychiatry"},{"key":"4398_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1326-9-30","volume":"9","author":"S Srodulski","year":"2014","unstructured":"Srodulski, S. et al. Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of Amylin. Mol. Neurodegener. 9, 30 (2014).","journal-title":"Mol. Neurodegener."},{"key":"4398_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JAD-160047","volume":"53","author":"N Verma","year":"2016","unstructured":"Verma, N. et al. Intraneuronal amylin deposition, peroxidative membrane injury and increased IL-1\u03b2 synthesis in brains of Alzheimer\u2019s disease patients with type-2 diabetes and in diabetic HIP rats. J. Alzheimers Dis. 53, 259\u2013272 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"4398_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The consortium to establish a registry for Alzheimer\u2019s disease (CERAD): Part II. standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013479 (1991).","journal-title":"Neurology"},{"key":"4398_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"4398_CR29","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","volume":"66","author":"PT Nelson","year":"2007","unstructured":"Nelson, P. T. et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort. J. Neuropathol. Exp. Neurol. 66, 1136\u20131146 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"4398_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2174\/156720512801322591","volume":"9","author":"FA Schmitt","year":"2012","unstructured":"Schmitt, F. A. et al. University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures, and neuropathology. Curr. Alzheimer Res. 9, 724\u2013733 (2012).","journal-title":"Curr. Alzheimer Res."},{"key":"4398_CR31","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/NEN.0b013e31829a25b9","volume":"72","author":"PT Nelson","year":"2013","unstructured":"Nelson, P. T. et al. Apoe-\u03b52 and APOE-\u03b54 correlate with increased amyloid accumulation in cerebral vasculature. J. Neuropathol. Exp. Neurol. 72, 708\u2013715 (2013).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"4398_CR32","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","volume":"53","author":"AE Butler","year":"2004","unstructured":"Butler, A. E. et al. Diabetes due to a progressive defect in \u03b2-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat). Diabetes 53, 1509\u20131516 (2004).","journal-title":"Diabetes"},{"key":"4398_CR33","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1161\/01.CIR.0000092948.04444.C7","volume":"108","author":"DE Berkowitz","year":"2003","unstructured":"Berkowitz, D. E. et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108, 2000\u20132006 (2003).","journal-title":"Circulation"},{"key":"4398_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.kint.2019.07.028","volume":"97","author":"N Verma","year":"2020","unstructured":"Verma, N. et al. Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries. Kidney Int. 97, 143\u2013155 (2020).","journal-title":"Kidney Int."},{"key":"4398_CR35","doi-asserted-by":"publisher","first-page":"104834","DOI":"10.1016\/j.nbd.2020.104834","volume":"139","author":"AL Lin","year":"2020","unstructured":"Lin, A. L. et al. APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer\u2019s disease. Neurobiol. Dis. 139, 104834 (2020).","journal-title":"Neurobiol. Dis."},{"key":"4398_CR36","doi-asserted-by":"publisher","first-page":"eaaf9647","DOI":"10.1126\/scisignal.aaf9647","volume":"10","author":"MA Nystoriak","year":"2017","unstructured":"Nystoriak, M. A. et al. Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes. Sci. Signal. 10, eaaf9647 (2017).","journal-title":"Sci. Signal."},{"key":"4398_CR37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata, M. et al. Clearance of Alzheimer\u2019s amyloid-\u03b21\u201340 peptide from brain by LDL receptor\u2013related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489\u20131499 (2000).","journal-title":"J. Clin. Invest."},{"key":"4398_CR38","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1172\/JCI11013","volume":"106","author":"DE Kang","year":"2000","unstructured":"Kang, D. E. et al. Modulation of amyloid \u03b2-protein clearance and Alzheimer\u2019s disease susceptibility by the LDL receptor\u2013related protein pathway. J. Clin. Invest. 106, 1159\u20131166 (2000).","journal-title":"J. Clin. Invest."},{"key":"4398_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Storck","year":"2015","unstructured":"Storck, S. E. et al. Endothelial LRP1 transports amyloid-\u03b21\u201342 across the blood-brain barrier. J. Clin. Invest. 126, 123\u2013136 (2015).","journal-title":"J. Clin. Invest."},{"key":"4398_CR40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1124\/mol.109.061754","volume":"77","author":"AM Hartz","year":"2010","unstructured":"Hartz, A. M., Miller, D. S. & Bauer, B. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-\u03b2 in a mouse model of Alzheimer\u2019s disease. Mol. Pharmacol. 77, 715\u2013723 (2010).","journal-title":"Mol. Pharmacol."},{"key":"4398_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fpsyt.2012.00054","volume":"3","author":"A Wolf","year":"2012","unstructured":"Wolf, A., Bauer, B. & Hartz, A. M. ABC transporters and the Alzheimer\u2019s disease enigma. Front. Psychiatry 3, 54 (2012).","journal-title":"Front. Psychiatry"},{"key":"4398_CR42","doi-asserted-by":"publisher","first-page":"14113","DOI":"10.1021\/bi0004192","volume":"39","author":"PE Fielding","year":"2000","unstructured":"Fielding, P. E., Nagao, K., Hakamata, H., Chimini, G. & Fielding, C. J. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to Apolipoprotein A-1. Biochemistry 39, 14113\u201314120 (2000).","journal-title":"Biochemistry"},{"key":"4398_CR43","doi-asserted-by":"publisher","first-page":"23742","DOI":"10.1074\/jbc.M102348200","volume":"276","author":"N Wang","year":"2001","unstructured":"Wang, N., Silver, D. L., Thiele, C. & Tall, A. R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 276, 23742\u201323747 (2001).","journal-title":"J. Biol. Chem."},{"key":"4398_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCRESAHA.117.305781","volume":"117","author":"JX Wang","year":"2015","unstructured":"Wang, J. X. et al. MicroRNA-103\/107 regulate programmed necrosis and myocardial ischemia\/reperfusion injury through targeting FADD. Circ. Res. 117, 352\u2013363 (2015).","journal-title":"Circ. Res."},{"key":"4398_CR45","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.celrep.2018.07.010","volume":"24","author":"PL Leslie","year":"2018","unstructured":"Leslie, P. L., Franklin, D. A., Liu, Y. & Zhang, Y. p53 regulates the expression of LRP1 and apoptosis through a stress intensity-dependent MicroRNA feedback loop. Cell Rep. 24, 1484\u20131495 (2018).","journal-title":"Cell Rep."},{"key":"4398_CR46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"4398_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold, S. E. et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat. Rev. Neurol. 14, 168\u2013181 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"4398_CR48","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar, D. & Craft, S. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 19, 758\u2013766 (2020).","journal-title":"Lancet Neurol."},{"key":"4398_CR49","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneur.64.4.570","volume":"64","author":"JA Luchsinger","year":"2007","unstructured":"Luchsinger, J. A. et al. Relation of diabetes to mild cognitive impairment. Arch. Neurol. 64, 570 (2007).","journal-title":"Arch. Neurol."},{"key":"4398_CR50","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1161\/STROKEAHA.121.034363","volume":"52","author":"F Despa","year":"2021","unstructured":"Despa, F. & Goldstein, L. B. Amylin dyshomeostasis hypothesis: small vessel-type ischemic stroke in the setting of type-2 diabetes. Stroke 52, e244\u2013e249 (2021).","journal-title":"Stroke"},{"key":"4398_CR51","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.2337\/db16-0044","volume":"65","author":"M Liu","year":"2016","unstructured":"Liu, M. et al. Hyperamylinemia increases IL-1\u03b2 synthesis in the heart via peroxidative sarcolemmal injury. Diabetes 65, 2772\u20132783 (2016).","journal-title":"Diabetes"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04398-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T18:23:11Z","timestamp":1701627791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04398-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4398"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-04398-2","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"8 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}